THE CHEMOURS COMPANY

CC
Delayed Quote. Delayed  - 06/11 04:10:00 pm
37.41USD +0.62%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2020 2021
Net sales1 4 9695 827
EBITDA1 8791 198
Operating profit (EBIT)1 559865
Operating Margin 11,2%14,9%
Pre-Tax Profit (EBT) --
Net income1 -541
Net margin -9,29%
EPS2 1,323,21
Dividend per Share2 1,001,00
Last update 02/11/202106/09/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2020 2021
Net Debt1 2 9212 825
Net Cash position1 --
Leverage (Debt / EBITDA) 3,32x2,36x
Free Cash Flow1 540491
ROE (Net Profit / Equities) 43,8%52,0%
Shareholders' equity1 -1 041
ROA (Net Profit / Asset) 4,59%7,00%
Assets1 -7 733
Book Value Per Share2 4,936,86
Cash Flow per Share2 -4,21
Capex1 267344
Capex / Sales 5,37%5,90%
Last update 02/11/202105/20/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 6 192 M $ -
Entreprise Value (EV) 9 018 M $ 8 733 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) 11,7x 9,98x
Capitalization / Revenue 1,06x 1,01x
EV / Revenue 1,55x 1,47x
EV / EBITDA 7,52x 6,79x
Yield (DPS / Price) 2,66% 2,77%
Price to book (Price / BVPS) 5,46x 4,13x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 14,9% 15,7%
Operating Leverage (Delta EBIT / Delta Sales) 3,18x 2,08x
Net Margin (Net Profit / Revenue) 9,29% 10,3%
ROA (Net Profit / Asset) 7,00% 7,56%
ROE (Net Profit / Equities) 52,0% 43,9%
Rate of Dividend 31,0% 27,6%
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   5,90% 6,30%
Cash Flow / Sales 12,0% 13,9%
Capital Intensity (Assets / Sales) 1,33x 1,36x
Financial Leverage (Net Debt / EBITDA) 2,36x 1,91x
Price Earning Ratio
EPS & Dividend